Copyright Reports & Markets. All rights reserved.

Global Respiratory Distress Syndrome Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Respiratory Distress Syndrome Market Overview

    • 1.1 Product Overview and Scope of Respiratory Distress Syndrome
    • 1.2 Classification of Respiratory Distress Syndrome by Types
      • 1.2.1 Global Respiratory Distress Syndrome Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Respiratory Distress Syndrome Revenue Market Share by Types in 2018
      • 1.2.3 Poractant Alfa
      • 1.2.4 Beractant
      • 1.2.5 Calfactant
      • 1.2.6 Others
    • 1.3 Global Respiratory Distress Syndrome Market by Application
      • 1.3.1 Global Respiratory Distress Syndrome Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Very Preterm Infants
      • 1.3.3 Moderate to Late Preterm Infants
      • 1.3.4 Others
    • 1.4 Global Respiratory Distress Syndrome Market by Regions
      • 1.4.1 Global Respiratory Distress Syndrome Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Respiratory Distress Syndrome Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Respiratory Distress Syndrome Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Respiratory Distress Syndrome Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Respiratory Distress Syndrome Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Respiratory Distress Syndrome Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Respiratory Distress Syndrome (2014-2024)

    2 Company Profiles

    • 2.1 Chiesi Farmaceutici
      • 2.1.1 Business Overview
      • 2.1.2 Respiratory Distress Syndrome Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Market Breakdown by Regions
      • 2.2.1 Business Overview
      • 2.2.2 Respiratory Distress Syndrome Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Market Breakdown by Regions Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 AbbVie
      • 2.3.1 Business Overview
      • 2.3.2 Respiratory Distress Syndrome Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 CR-Double Crane
      • 2.4.1 Business Overview
      • 2.4.2 Respiratory Distress Syndrome Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Noargen
      • 2.5.1 Business Overview
      • 2.5.2 Respiratory Distress Syndrome Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 ONY Biotech
      • 2.6.1 Business Overview
      • 2.6.2 Respiratory Distress Syndrome Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Europe
      • 2.7.1 Business Overview
      • 2.7.2 Respiratory Distress Syndrome Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Europe Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 JW Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Respiratory Distress Syndrome Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Yuhan Corporation
      • 2.9.1 Business Overview
      • 2.9.2 Respiratory Distress Syndrome Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 North America
      • 2.10.1 Business Overview
      • 2.10.2 Respiratory Distress Syndrome Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 North America Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 China
      • 2.11.1 Business Overview
      • 2.11.2 Respiratory Distress Syndrome Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 China Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Korea
      • 2.12.1 Business Overview
      • 2.12.2 Respiratory Distress Syndrome Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Korea Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 RoW
      • 2.13.1 Business Overview
      • 2.13.2 Respiratory Distress Syndrome Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 RoW Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Respiratory Distress Syndrome Market Competition, by Players

    • 3.1 Global Respiratory Distress Syndrome Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Respiratory Distress Syndrome Players Market Share
      • 3.2.2 Top 10 Respiratory Distress Syndrome Players Market Share
    • 3.3 Market Competition Trend

    4 Global Respiratory Distress Syndrome Market Size by Regions

    • 4.1 Global Respiratory Distress Syndrome Revenue and Market Share by Regions
    • 4.2 North America Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 4.5 South America Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

    5 North America Respiratory Distress Syndrome Revenue by Countries

    • 5.1 North America Respiratory Distress Syndrome Revenue by Countries (2014-2019)
    • 5.2 USA Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

    6 Europe Respiratory Distress Syndrome Revenue by Countries

    • 6.1 Europe Respiratory Distress Syndrome Revenue by Countries (2014-2019)
    • 6.2 Germany Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 6.3 UK Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 6.4 France Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Respiratory Distress Syndrome Revenue by Countries

    • 7.1 Asia-Pacific Respiratory Distress Syndrome Revenue by Countries (2014-2019)
    • 7.2 China Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 7.5 India Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

    8 South America Respiratory Distress Syndrome Revenue by Countries

    • 8.1 South America Respiratory Distress Syndrome Revenue by Countries (2014-2019)
    • 8.2 Brazil Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Respiratory Distress Syndrome by Countries

    • 9.1 Middle East and Africa Respiratory Distress Syndrome Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)

    10 Global Respiratory Distress Syndrome Market Segment by Type

    • 10.1 Global Respiratory Distress Syndrome Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Respiratory Distress Syndrome Market Forecast by Type (2019-2024)
    • 10.3 Poractant Alfa Revenue Growth Rate (2014-2024)
    • 10.4 Beractant Revenue Growth Rate (2014-2024)
    • 10.5 Calfactant Revenue Growth Rate (2014-2024)
    • 10.6 Others Revenue Growth Rate (2014-2024)

    11 Global Respiratory Distress Syndrome Market Segment by Application

    • 11.1 Global Respiratory Distress Syndrome Revenue Market Share by Application (2014-2019)
    • 11.2 Respiratory Distress Syndrome Market Forecast by Application (2019-2024)
    • 11.3 Very Preterm Infants Revenue Growth (2014-2019)
    • 11.4 Moderate to Late Preterm Infants Revenue Growth (2014-2019)
    • 11.5 Others Revenue Growth (2014-2019)

    12 Global Respiratory Distress Syndrome Market Size Forecast (2019-2024)

    • 12.1 Global Respiratory Distress Syndrome Market Size Forecast (2019-2024)
    • 12.2 Global Respiratory Distress Syndrome Market Forecast by Regions (2019-2024)
    • 12.3 North America Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
    • 12.4 Europe Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
    • 12.6 South America Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Description

      Scope of the Report:
      The global Respiratory Distress Syndrome market is valued at 360.1 million USD in 2018 and is expected to reach 442.6 million USD by the end of 2024, growing at a CAGR of 5.3% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Respiratory Distress Syndrome.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Respiratory Distress Syndrome market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Respiratory Distress Syndrome market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Chiesi Farmaceutici
      Market Breakdown by Regions
      AbbVie
      CR-Double Crane
      Noargen
      ONY Biotech
      Europe
      JW Pharmaceuticals
      Yuhan Corporation
      North America
      China
      Korea
      RoW

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Poractant Alfa
      Beractant
      Calfactant
      Others

      Poractant Alpha's largest market share is broken down to 67%.

      Market Segment by Applications, can be divided into
      Very Preterm Infants
      Moderate to Late Preterm Infants
      Others

      Very Preterm shapes the largest segment of the application market

      Buy now